Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-13-000432
Filing Date
2013-08-09
Accepted
2013-08-09 13:56:27
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q skin0806form10q.htm 10-Q 155732
2 EXHIBIT 31.1 skin0806form10qex311.htm EX-31 7985
3 EXHIBIT 31.2 skin0806form10qex312.htm EX-31 7984
4 EXHIBIT 32.1 skin0806form10qex321.htm EX-32 4191
  Complete submission text file 0001554795-13-000432.txt   1039311

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE skin-20130630.xml EX-101.INS 33995
6 XBRL SCHEMA FILE skin-20130630.xsd EX-101.SCH 5990
7 XBRL CALCULATION FILE skin-20130630_cal.xml EX-101.CAL 19205
8 XBRL DEFINITION FILE skin-20130630_def.xml EX-101.DEF 4264
9 XBRL LABEL FILE skin-20130630_lab.xml EX-101.LAB 61251
10 XBRL PRESENTATION FILE skin-20130630_pre.xml EX-101.PRE 43864
Mailing Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106 8013232395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

EIN.: 870458170 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30991 | Film No.: 131025801
SIC: 6770 Blank Checks